Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 12555
TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708839BDBM708839(US20240425513, Example 20)
Affinity DataIC50: 1nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708863BDBM708863(US20240425513, Example 44)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708845BDBM708845(US20240425513, Example 26)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708846BDBM708846(US20240425513, Example 27)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708843BDBM708843(US20240425513, Example 24)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708844BDBM708844(US20240425513, Example 25)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708841BDBM708841(US20240425513, Example 22)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708840BDBM708840(US20240425513, Example 21)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708853BDBM708853(US20240425513, Example 34)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708854BDBM708854(US20240425513, Example 35)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708851BDBM708851(US20240425513, Example 32)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708852BDBM708852(US20240425513, Example 33)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708847BDBM708847(US20240425513, Example 28)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708848BDBM708848(US20240425513, Example 29)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708862BDBM708862(US20240425513, Example 43)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708859BDBM708859(US20240425513, Example 40)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708860BDBM708860(US20240425513, Example 41)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708857BDBM708857(US20240425513, Example 38)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708858BDBM708858(US20240425513, Example 39)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708855BDBM708855(US20240425513, Example 36)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708856BDBM708856(US20240425513, Example 37)
Affinity DataIC50: 50nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708837BDBM708837(US20240425513, Example 18)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708833BDBM708833(US20240425513, Example 14)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708834BDBM708834(US20240425513, Example 15)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708842BDBM708842(US20240425513, Example 23)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708822BDBM708822(US20240425513, Example 3)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708849BDBM708849(US20240425513, Example 30)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708850BDBM708850(US20240425513, Example 31)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708861BDBM708861(US20240425513, Example 42)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708829BDBM708829(US20240425513, Example 10)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708828BDBM708828(US20240425513, Example 9)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708825BDBM708825(US20240425513, Example 6)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708823BDBM708823(US20240425513, Example 4)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708824BDBM708824(US20240425513, Example 5)
Affinity DataIC50: 275nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708838BDBM708838(US20240425513, Example 19)
Affinity DataIC50: 750nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708832BDBM708832(US20240425513, Example 13)
Affinity DataIC50: 750nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708827BDBM708827(US20240425513, Example 8)
Affinity DataIC50: 750nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708821BDBM708821(US20240425513, Example 2)
Affinity DataIC50: 1.00E+3nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708835BDBM708835(US20240425513, Example 16)
Affinity DataIC50: 1.00E+3nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708836BDBM708836(US20240425513, Example 17)
Affinity DataIC50: 1.00E+3nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708820BDBM708820(US20240425513, Example 1)
Affinity DataIC50: 1.00E+3nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708831BDBM708831(US20240425513, Example 12)
Affinity DataIC50: 1.00E+3nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708830BDBM708830(US20240425513, Example 11)
Affinity DataIC50: 1.00E+3nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 28(Human)
Carmot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 708826BDBM708826(US20240425513, Example 7)
Affinity DataIC50: 1.00E+3nMAssay Description:Each assay was performed in a final volume of 8 μl in assay buffer containing 10 mM HEPES pH 7.3 ((1 M, pH 7.3 solution, (VWR J848), 100 mM NaCl (5 M...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent